Pediatrix Medical Group (NYSE:MD) Hits New 1-Year High - Still a Buy?

Key Points

• Pediatrix Medical Group has reached a new 52-week high, trading at $18.22, with a current price of $17.86 and a significant trading volume of 88,975 shares.
• Analysts have upgraded the stock's ratings, with Wall Street Zen and Zacks Research giving it a "strong-buy" rating, while the average analyst rating stands at "Hold" with a price target of $16.79.
• The company reported earnings of $0.53 per share for the last quarter, surpassing estimates, despite a 7.1% decline in revenue compared to the previous year, totaling $468.84 million.

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) hit a new 52-week high on Tuesday . The company traded as high as $18.22 and last traded at $17.86, with a volume of 88975 shares trading hands. The stock had previously closed at $17.64.

Analyst Ratings Changes

MD has been the topic of several analyst reports. Leerink Partners increased their price objective on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a "market perform" rating in a research note on Friday, September 5th. Wall Street Zen raised shares of Pediatrix Medical Group from a "buy" rating to a "strong-buy" rating in a report on Saturday. Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a report on Monday, August 11th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Pediatrix Medical Group in a report on Saturday, September 27th. Finally, UBS Group increased their price target on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research note on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group currently has an average rating of "Hold" and an average price target of $16.79.

Pediatrix Medical Group Stock Performance

The stock has a fifty day moving average of $15.92 and a 200-day moving average of $14.43. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70. The stock has a market cap of $1.54 billion, a PE ratio of 13.71 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.11. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The business had revenue of $468.84 million for the quarter, compared to analyst estimates of $464.37 million. During the same quarter in the previous year, the company posted $0.34 earnings per share. The company's revenue for the quarter was down 7.1% compared to the same quarter last year. On average, equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of MD. GAMMA Investing LLC increased its holdings in shares of Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after purchasing an additional 1,765 shares in the last quarter. Marshall & Sullivan Inc. WA purchased a new stake in shares of Pediatrix Medical Group during the 2nd quarter worth approximately $41,000. Canada Pension Plan Investment Board acquired a new stake in shares of Pediatrix Medical Group in the 2nd quarter worth approximately $83,000. AlphaQuest LLC increased its stake in Pediatrix Medical Group by 16.0% in the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after purchasing an additional 811 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new position in Pediatrix Medical Group during the second quarter worth $99,000. Institutional investors and hedge funds own 97.71% of the company's stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.